Patients' experiences of chemotherapy: Side-effects of carboplatin in the treatment of carcinoma of the ovary

European Journal of Cancer Care

Volumn 6, Issue 1, 1997, Pages 59-71

  Buckingham, Rhona ^a   Fitt, Jane ^a   Sitzia, John ^a  

^a WORTHING HOSPITAL   (United Kingdom)

Author keywords

Carboplatin; Chemotherapy toxicity; Clinical assessment; Fatigue; Nausea; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HUMAN; MIDDLE AGED; OVARY TUMOR; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ATTITUDE TO HEALTH; CARBOPLATIN; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; QUESTIONNAIRES;

EID: 0031090210     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2354.1997.tb00270.x     Document Type: Article

References (17)

1. Bailey D.M. (1991) Research for the Health Professional: a practical guide. F.A. Davis Company, Philadelphia.
2. Bellg A.J., Morrow G.R., Barry M.J., Angel C. & du Beshter B. (1995) Autonomic measures associated with chemotherapy-related nausea: techniques and issues. Cancer Investigation, 13, 313-323.
3. Christensen Jamar S. (1994) Fatigue in women receiving chemotherapy for ovarian cancer. In: Management of pain, fatigue and nausea (eds. S.G. Funk et al.), pp. 224-233. Macmillan, London.
4. Daly M.B. (1992) The epidemiology of ovarian cancer. Hematology/Oncology Clinics of North America, 6, 729-738.
5. DeGeorge D., Gray J.J., Fetting J.H. & Rolls B.j. (1990) Weight gain in patients with breast cancer receiving adjuvant treatment as a function of restraint, disinhibition, and hunger. Oncology Nursing Forum, 17, 23-30.
6. Foster B.J., Clagett-Carr K., Leyland-Jones B. & Hoth D. (1985) Results of NCI-sponsored phase I trials with carboplatin. Cancer Treatment Reviews, 12A, 43-49.
7. Hendrick A.M., Simmons D. & Cantwell B.M.J. (1992) Allergic reactions to carboplatin. Annals of Oncology, 3, 238-240.
8. Rowland J.S., Baker M.G. & Poe T. (1990) Does patient education cause side effects? a controlled trial. Journal of Family Practice, 31, 62-64.
9. Huntington M.O. (1985) Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer, 56, 472-474.
10. Joshua A. &. King T. (1995) 1995-96 Nursing Drug Reference. Times International Publishers, London.
11. Lamb C.L., Green S.S. & Heron J. (1994) Can physicians warn patients of potential side effects without fear of causing those side effects? Archives of Internal Medicine, 154, 2753-2756.
12. Meyerowitz B., Sparks F. & Spears I. (1979) Adjuvant chemotherapy for breast carcinoma: psychosocial implications. Cancer, 43, 1613-1618.
13. Padilla G.V. & Grant M.M. (1985) Quality of Life as a cancer nursing outcome variable. Advances in Nursing Science, 8, 45-60.
14. Pickard-Holley S. (1991) Fatigue in cancer patients - a descriptive study. Cancer Nursing, 14, 13-19.
15. Rankin E.M. and Pitts J.F. (1993) Ophthalmic toxicity during carboplatin therapy. Annals of Oncology, 4, 337-338.
16. Richardson A. (1995) Fatigue in cancer patients: a review of the literature. European Journal of Cancer Care, 4, 20-32.
17. Scott J.S., Bates T.D., Blackledge G.R., Buckley C.H., Brown J.M., Chamberlain J.O.P., Dawson T., Dische S., Johnson R.J., Morrison J.M., Scott I.V., Shepherd J.H., & Whitehouse J.M.A. (1991) Management of ovarian cancer. Current clinical practices (1991). Report of the Standing Subcommittee on Cancer of the Standing Medical Advisory Committee. HMSO, London.